Medical Information on Acute Myelogenous Leukemia
(HM001)
Leukemia is a cancer of the white blood cells and bone marrow. It is characterized by uncontrolled growth of blood cells. There are four major types of leukemia: acute or chronic myelogenous (AML, CML) and acute or chronic lymphocytic (ALL, CLL). The terms myelogenous and lymphocytic denote the type of cell involved.
Acute leukemia is a rapidly progressing disease that results in the accumulation of immature, functionless cells in the marrow and blood. The marrow often can no longer produce enough normal red and white blood cells and platelets.
Acute Myelogenous Leukemia (AML) is the most common type of leukemia in adults with approximately 10,100 new cases every year. AML accounts for just under half of cases of childhood leukemia.
The Medifocus Guide on Acute Myelogenous Leukemia provides answers to the following important questions and medical issues:
- What are the most common symptoms of Acute Myelogenous Leukemia?
- Are there any recognized risk factors for developing Acute Myelogenous Leukemia?
- What kinds of medical tests are used to establish the diagnosis of Acute Myelogenous Leukemia?
- What is the current standard of care for the treatment of Acute Myelogenous Leukemia?
- What treatment options are available for the management of Acute Myelogenous Leukemia?
- Are there any promising new developments or potential breakthroughs in treatment?
- Who are the most notable medical authorities who specialize in Acute Myelogenous Leukemia?
- Where are the leading hospitals and centers of research for Acute Myelogenous Leukemia?
- What are the most important questions to ask my doctor about Acute Myelogenous Leukemia?
This MediFocus Guide contains an extensive listing of citations and abstracts of recent journal articles that have been published about this condition in trustworthy medical journals. This is the same type of information that is available to physicians and other health care professionals. Click Medifocus
- New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities.
Stem Cells. 2000 - Acute myelogenous leukaemia and myelomonocytic blast crisis following polycythemia vera in HIV positive patients: report of cases and review of the literature.
Annals of Oncology. 2000 - Treatment of acute myelogenous leukemia in older adults.
Leukemia. 2000 - Treatment of relapsed and refractory acute myelogenous leukemia.
Leukemia. 2000 - Acute myelogenous leukemia and aging. Clinical interactions.
Hematology - Oncology Clinics of North America. 2000 - Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement.
Cancer. 2000 - Management of relapsed acute myeloid leukaemia.
British Journal of Haematology. 1999 - New developments in the treatment of acute myeloid leukemia.
Advances in Experimental Medicine & Biology. 1999 - Tailoring the treatment of acute myeloid leukemia.
Current Opinion in Hematology. 1999 - Post-transplant acute myeloid leukemia (PT-AML).
Leukemia. 1999
